# In FDA compounding adcomm, advisers urge against restrictions on 1st of 7 peptides - Fierce Pharma

*Источник: Fierce Pharma*
*Дата: 2026-07-23*
*Язык: en*

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxPVUVYdjJ5VGUxZG45SVFRVDlTWXZtN0NmYVpCNmZNTHh0RWRtbUNEN25YSmN6TnRBMExibnRXSzRjSWdBY3BfTmV0RlQ3azhoY0VGazFQektCcFJCLTNPZHVCUlcwWVU2bE9FampCRW9Pd2pRdzFFenhkSHVEaGpVSjNvVy0ycGtzU1Qwd0hIdFNCUlE0aG5ZYjlnQkwxUm1ObUtv?oc=5" target="_blank">In FDA compounding adcomm, advisers urge against restrictions on 1st of 7 peptides</a>&nbsp;&nbsp;<font color="#6f6f6f">Fierce Pharma</font>

[Оригинал](https://www.fiercepharma.com/pharma/fda-adcomm-advisers-recommend-removal-restrictions-1st-7-peptides)